Short-term Circuit Training on Muscle Mass and Quality of Life in Sedentary Postmenopausal Women

Launched by LOMA LINDA UNIVERSITY · Jun 5, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the effects of circuit training on improving muscle strength and overall quality of life for postmenopausal women who are not currently active. The goal is to see if this type of exercise can help women feel better both physically and mentally after menopause. The trial is looking for women aged 50 to 75 who have not been involved in structured exercise programs for at least six months and are in good enough health to participate.

If you or someone you know is interested in joining, you would need to be a woman within the age range mentioned and have stopped menstruating for at least a year. Participants can expect to take part in a supervised exercise program that focuses on strength training. It's important to note that women who are already active or have certain health conditions may not be eligible for this study. This trial could be a great opportunity to improve your health and well-being after menopause!

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Females aged between 50 and 75 years.
• • Self-reported postmenopausal status (i.e., cessation of menstruation for a minimum of 12 months).
• • Physically capable of participating in an exercise intervention.
• • No engagement in structured resistance or aerobic training programs in the six months preceding the study.
• Exclusion Criteria:
• • Classification as moderate and highly active on the International Physical Activity Questionnaire (IPAQ) (600-3000 MET-minutes/week for "moderate" and higher than 3000 MET-minutes/week for "high" score)
• • Diagnosis of any health condition that constitutes a contraindication to physical exercise (e.g., significant cardiovascular disease, orthopedic or neuromuscular restrictions impacting exercise performance or safety).
• • Regular use of medication with the potential to affect study outcomes (e.g., corticosteroids, immunosuppressants).

Trial Officials